Nov 6 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL PROVIDES CLINICAL UPDATE ON ITS LEAD VACCINE CANDIDATE, BRIAVAX
* BRIAVAX STUDY REMAINS ON TRACK TO ANNOUNCE DATA ON FIRST 10 PATIENTS IN Q1 OF 2018
* ENROLLMENT IN BRIAVAX ROLL-OVER COMBINATION STUDY MAY COMMENCE AS EARLY AS Q1 OF 2018